Showing results (261-270 of 639) with videos related to
Sort By:
Pageof 64
The Journal of Liquid Biopsy|March 3, 2025
Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applicationsClaudia Parisi, Marco Tagliamento, Laila Belcaid, et al.Cancers|April 3, 2021
Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive PatientsValérie Gounant, Michael Duruisseaux, Ghassen Soussi, et al.International Journal of Cancer|January 6, 2011
The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH studyEmilie Lanoy, Jean-Philippe Spano, Fabrice Bonnet, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2009
Use of adjuvant chemotherapy in non-small cell lung cancer in routine practiceChristophe Massard, Pierre Tran Ba Loc, Vincent Haddad, et al.Cancer Biomarkers : Section a of Disease Markers|December 19, 2014
Detection of circulating tumour cells in peripheral blood of patients with malignant pleural mesotheliomaJacques Raphael, Christophe Massard, Inna Y Gong, et al.Pathology, Research and Practice|May 31, 2017
EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathologyVincent Thomas De Montpréville, Maria-Rosa Ghigna, Ludovic Lacroix, et al.Oncotarget|March 14, 2019
Correction: EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCRJordan Madic, Cécile Jovelet, Julien Lopez, et al.Oncology (Williston Park, N.Y.)|January 20, 2005
The promise of pharmacogenomics: gemcitabine and pemetrexedRafael Rosell, Miquel Taron, Jose Miguel Sanchez, et al.Onkologie|June 19, 2013
Clinical benefit for patients with non-small cell lung cancer enrolled in phase I trialsAntonin Levy, Carlos Gomez-Roca, Christophe Massard, et al.Oncotarget|January 17, 2019
EGFR C797S, EGFR T790M and EGFR sensitizing mutations in non-small cell lung cancer revealed by six-color crystal digital PCRJordan Madic, Cécile Jovelet, Julien Lopez, et al.Pageof 64